467 related articles for article (PubMed ID: 31385774)
1. Design, Synthesis, Antimalarial Activity and Docking Study of 7-Chloro-4- (2-(substituted benzylidene)hydrazineyl)quinolines.
Kalita J; Chetia D; Rudrapal M
Med Chem; 2020; 16(7):928-937. PubMed ID: 31385774
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Antiplasmodial Potential of C2 and C8 Modified Quinolines: in vitro and in silico Study.
Kumar R; Sharma R; Kumar I; Upadhyay P; Dhiman AK; Kumar R; Kumar R; Purohit R; Sahal D; Sharma U
Med Chem; 2019; 15(7):790-800. PubMed ID: 30324888
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of mono- and bisquinoline methanamine derivatives as potential antiplasmodial agents.
Bokosi FRB; Beteck RM; Mbaba M; Mtshare TE; Laming D; Hoppe HC; Khanye SD
Bioorg Med Chem Lett; 2021 Apr; 38():127855. PubMed ID: 33609655
[TBL] [Abstract][Full Text] [Related]
4. Quinoline carboxamide core moiety-based compounds inhibit P. falciparumfalcipain-2: Design, synthesis and antimalarial efficacy studies.
Singh A; Kalamuddin M; Maqbool M; Mohmmed A; Malhotra P; Hoda N
Bioorg Chem; 2021 Mar; 108():104514. PubMed ID: 33280833
[TBL] [Abstract][Full Text] [Related]
5. Hybrid molecules with potential in vitro antiplasmodial and in vivo antimalarial activity against drug-resistant Plasmodium falciparum.
Feng LS; Xu Z; Chang L; Li C; Yan XF; Gao C; Ding C; Zhao F; Shi F; Wu X
Med Res Rev; 2020 May; 40(3):931-971. PubMed ID: 31692025
[TBL] [Abstract][Full Text] [Related]
6. Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives.
Vijayaraghavan S; Mahajan S
Bioorg Med Chem Lett; 2017 Apr; 27(8):1693-1697. PubMed ID: 28318947
[TBL] [Abstract][Full Text] [Related]
7. Quinoline hybrids and their antiplasmodial and antimalarial activities.
Hu YQ; Gao C; Zhang S; Xu L; Xu Z; Feng LS; Wu X; Zhao F
Eur J Med Chem; 2017 Oct; 139():22-47. PubMed ID: 28800458
[TBL] [Abstract][Full Text] [Related]
8. New Potential Antimalarial Agents: Design, Synthesis and Biological Evaluation of Some Novel Quinoline Derivatives as Antimalarial Agents.
Radini IA; Elsheikh TM; El-Telbani EM; Khidre RE
Molecules; 2016 Jul; 21(7):. PubMed ID: 27428939
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and characterization of novel aminoalcohol quinolines with strong in vitro antimalarial activity.
Dassonville-Klimpt A; Schneider J; Damiani C; Tisnerat C; Cohen A; Azas N; Marchivie M; Guillon J; Mullié C; Agnamey P; Totet A; Dormoi J; Taudon N; Pradines B; Sonnet P
Eur J Med Chem; 2022 Jan; 228():113981. PubMed ID: 34782182
[TBL] [Abstract][Full Text] [Related]
10. Quinoline Containing Side-chain Antimalarial Analogs: Recent Advances and Therapeutic Application.
Joshi MC; Egan TJ
Curr Top Med Chem; 2020; 20(8):617-697. PubMed ID: 31985377
[TBL] [Abstract][Full Text] [Related]
11. 4-anilinoquinoline triazines: a novel class of hybrid antimalarial agents.
Kumar A; Srivastava K; Kumar SR; Siddiqi MI; Puri SK; Sexana JK; Chauhan PM
Eur J Med Chem; 2011 Feb; 46(2):676-90. PubMed ID: 21194812
[TBL] [Abstract][Full Text] [Related]
12. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel ferrocene-quinoline conjugates and evaluation of their electrochemical and antiplasmodium properties.
Minić A; Van de Walle T; Van Hecke K; Combrinck J; Smith PJ; Chibale K; D'hooghe M
Eur J Med Chem; 2020 Feb; 187():111963. PubMed ID: 31865015
[TBL] [Abstract][Full Text] [Related]
14. Search for new pharmacophore as antimalarial agent: synthesis and antimalarial activity of some 2(3H)-furanones bearing quinoline moiety.
Alam MM; Sarkar DP; Alam O; Husain A; Marella A; Akhtar M; Shaquiquzzaman M; Khanna S
Acta Pol Pharm; 2011; 68(2):231-6. PubMed ID: 21485296
[TBL] [Abstract][Full Text] [Related]
15. 2,3,8-Trisubstituted Quinolines with Antimalarial Activity.
Martinez PDG; Krake SH; Poggi ML; Campbell SF; Willis PA; Dias LC
An Acad Bras Cienc; 2018; 90(1 Suppl 2):1215-1231. PubMed ID: 29791525
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antimalarial evaluation of novel isocryptolepine derivatives.
Whittell LR; Batty KT; Wong RP; Bolitho EM; Fox SA; Davis TM; Murray PE
Bioorg Med Chem; 2011 Dec; 19(24):7519-25. PubMed ID: 22055713
[TBL] [Abstract][Full Text] [Related]
17. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
[TBL] [Abstract][Full Text] [Related]
18. Novel series of 1,2,4-trioxane derivatives as antimalarial agents.
Rudrapal M; Chetia D; Singh V
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1159-1173. PubMed ID: 28870093
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Antiplasmodial Activity of Novel Fosmidomycin Derivatives and Conjugates with Artemisinin and Aminochloroquinoline.
Palla D; Antoniou AI; Baltas M; Menendez C; Grellier P; Mouray E; Athanassopoulos CM
Molecules; 2020 Oct; 25(20):. PubMed ID: 33096817
[TBL] [Abstract][Full Text] [Related]
20. In Vivo and In Vitro Optimization of Screening Antimalarial Hits toward Lead Molecules for Preclinical Development.
Fröhlich T; Tsogoeva SB
J Med Chem; 2016 Nov; 59(21):9668-9671. PubMed ID: 27775354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
